These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 7770875)
41. [Septic metastatic complications in facial furuncles and carbuncles]. Kudinova ES Stomatologiia (Mosk); 1999; 78(3):22-5. PubMed ID: 10368600 [TBL] [Abstract][Full Text] [Related]
42. [The effect of hyperbaric oxygenation on the urea content of the saliva in acute and chronic soft-tissue inflammation in the maxillofacial area]. Volozhin AI; Panin MG; Gnativ TV; Sel'tsovskaia GD; Sidel'nikova GM; Perova LA Patol Fiziol Eksp Ter; 1998; (4):20-2. PubMed ID: 9951297 [TBL] [Abstract][Full Text] [Related]
43. [The atypical and chronic course of suppurative inflammatory diseases of the maxillofacial area and the diagnostic and treatment methods]. Fomichev EV; Romanenko NV Stomatologiia (Mosk); 1996; Spec No():85-6. PubMed ID: 9281188 [No Abstract] [Full Text] [Related]
45. [The use of ozonized solutions in the combined treatment of odontogenic putrefactive-necrotic phlegmons of the maxillofacial area and neck]. Lazutikov OV; Lunev BV Stomatologiia (Mosk); 1996; Spec No():64-5. PubMed ID: 9281158 [No Abstract] [Full Text] [Related]
46. [Use of low-frequency vibration in the combined treatment of patients with phlegmons of the maxillofacial area]. Iunuskhodzhaev E Stomatologiia (Mosk); 1988; 67(2):28-9. PubMed ID: 3164122 [No Abstract] [Full Text] [Related]
47. [Effectiveness of transfusion therapy and the clinico-biochemical examination of patients with maxillofacial phlegmon]. Kulikova VS; Konobevtsev OF; Veretinskaia AG; Kosorukova NIa; Kulakov AA Stomatologiia (Mosk); 1984; 63(5):31-2. PubMed ID: 6593911 [No Abstract] [Full Text] [Related]
48. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area]. Khamitov FS; Faizov TT; Berim MG Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735 [No Abstract] [Full Text] [Related]
49. [The characteristics of managing and treating patients with suppurative-inflammatory processes of the maxillofacial area and diabetes mellitus]. Ivasenko PI; Ivankovich VA; Zagainaia NG; Stepanova OP; Tarasiuk SG Stomatologiia (Mosk); 1996; Spec No():58-9. PubMed ID: 9281150 [No Abstract] [Full Text] [Related]
50. [Odontogenic inflammatory diseases of the maxillofacial region]. Arzhantsev PZ; Levanov GG; Griaznov AM Voen Med Zh; 1978 Apr; (4):34-6. PubMed ID: 654136 [No Abstract] [Full Text] [Related]
51. [Treatment of acute odontogenic periostitis of the jaws in children under outpatient conditions]. Arifdzhanov AK; Agapova SN Stomatologiia (Mosk); 1986; 65(4):74-6. PubMed ID: 3462994 [No Abstract] [Full Text] [Related]
52. [Serum immunoglobulin content of patients with inflammatory diseases of the maxillofacial area]. Shcherbatiuk DI; Anestiiadi MIa Stomatologiia (Mosk); 1984; 63(5):37-9. PubMed ID: 6437017 [No Abstract] [Full Text] [Related]
53. [Principles of transfusion therapy for patients with phlegmons of the maxillofacial area]. Grishchuk SF; Konobevtsev OF; Chernousenko AS; Abdulaev ShIu; Gebel' GIa Stomatologiia (Mosk); 1987; 66(6):4-6. PubMed ID: 3481489 [No Abstract] [Full Text] [Related]
54. [Use of hemosorption in treating suppurative septic processes in the maxillofacial area]. Gubin MA; Rodionov VN; Prokhorenko ; Moiseenko VS; Bugakov EM Stomatologiia (Mosk); 1982; 61(6):76-7. PubMed ID: 6961603 [No Abstract] [Full Text] [Related]
55. [A computerized expert system for the diagnosis and prognosis of the course of acute odontogenic inflammatory diseases (DIAPRO)]. Taĭchenachev AIa; Vydrych VV; Vasil'ev EA Stomatologiia (Mosk); 1998; 77(3):66-7. PubMed ID: 9643119 [TBL] [Abstract][Full Text] [Related]
56. [Antiseptics in the combined treatment of patients with perimaxillary abscesses and phlegmons]. Biberman IaM; Starodubtsev VS; Shutova AP Stomatologiia (Mosk); 1996; 75(6):25-7. PubMed ID: 9214031 [TBL] [Abstract][Full Text] [Related]
57. [The use of physiotherapeutic factors in the combined treatment of patients with diseases of the maxillofacial area]. Ivasenko PI; Popov AK; Ponomarenko ID Stomatologiia (Mosk); 1996; Spec No():59-60. PubMed ID: 9281151 [No Abstract] [Full Text] [Related]
58. [The possibilities of using clinical blood analysis for the prognosis of the course of acute suppurative inflammatory processes in the soft tissues of the maxillofacial area]. Kurakin AV; Kuznetsova OI; Meshcheriakov DG Stomatologiia (Mosk); 1991; 70(1):35-7. PubMed ID: 2057948 [TBL] [Abstract][Full Text] [Related]
59. [Neutrophil-macrophage correlations during the healing of suppurative wounds in patients with phlegmons of the maxillofacial area undergoing combined treatment with the use of low-frequency ultrasound]. Mukhsinov ME; Bazhanov NN; Pol'skiĭ VI Stomatologiia (Mosk); 1989; 68(5):45-9. PubMed ID: 2588280 [TBL] [Abstract][Full Text] [Related]
60. [Use of heteroperitoneum in the treatment of maxillofacial phlegmons]. Gurov PN; Balmukhanov VN Vestn Khir Im I I Grek; 1970 Aug; 105(8):13-6. PubMed ID: 5495080 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]